FINWIRES · TerminalLIVE
FINWIRES

$OGN

23 stories mentioning OGN

Every FINWIRES story that references OGN, newest first.

Insider Trading

Organon Insider Bought Shares Worth $353,080, According to a Recent SEC Filing

Lynette Holzbaur, Senior Vice President and Corporate Controller, on May 06, 2026, executed a purchase for 26,448 shares in Organon (OGN) for $353,080. Following the Form 4 filing with the SEC, Holzbaur has control over a total of 52,851 common shares of the company, with 52,851 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1821825/000162828026031780/xslF345X05/wk-form4_1778162547.xmlPrice: $13.38, Change: $-0.03, Percent Change: -0.22%

$OGN
Research

Research Alert: CFRA Retains Hold Rating On Shares Of Organon & Co. Following Q1 Results

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our target price at $14.00, based on a P/E of 3.8x our 2027 EPS estimate. We lower our 2026 EPS estimate to $3.40 from $3.62 and maintain our 2027 EPS estimate at $3.71. Organon reported mixed Q1 2026 results, with revenues declining 4% Y/Y to $1,460M (-9% on a constant currency basis), reflecting headwinds across its Women's Health franchise, with sales down 16% Y/Y, particularly for Nexplanon. Yet, the company's biosimilar portfolio delivered robust growth, with revenues advancing 23% Y/Y, led by Hadlima's strong U.S. performance. Looking ahead, the successful closing of the pending Sun Pharmaceutical acquisition will be the key focus. On April 26, the company entered into a definitive merger agreement with Sun Pharmaceutical, which valued Organon at $11.75B. Joseph Morrissey, previously serving as Interim CEO, was appointed to the role on a permanent basis, which eliminates leadership uncertainty during this critical period, in our view.

$OGN
Research

Piper Sandler Upgrades Organon to Neutral From Underweight, Adjusts Price Target to $14 From $5

Organon (OGN) has an average rating of Underweight and mean price target of $11.25, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$OGN
US Markets

Nasdaq, S&P 500 Reach New Peaks; Oil Rises

The Nasdaq Composite and the S&P 500 notched fresh record closing highs on Monday even as oil prices moved higher amid stalled peace talks between the US and Iran.The Nasdaq edged up 0.2% to 24,887.1, while the S&P 500 gained 0.1% to 7,173.9, recording their highest finish ever for a second consecutive session. The Dow Jones Industrial Average fell 0.1% to 49,167.8. Most sectors were in the red, led by consumer staples, while communication services paced the gainers.Brent crude was last up 2.5% at $107.95 per barrel, while West Texas Intermediate crude rose 1.8% to $96.08.Iran's Foreign Minister Seyed Abbas Araghchi visited Pakistan twice over the weekend, while President Donald Trump called off US officials' previously announced trip to Islamabad.Iran has submitted a new proposal to reopen the Strait of Hormuz that includes delaying nuclear negotiations, Axios reported, citing a US official and two other sources."The lack of progress (in peace talks) means the market is tightening every day, requiring oil prices to reprice at higher levels," ING Bank said in a note on Monday.Trump was scheduled to meet with top national security officials on Monday to discuss the new Iranian proposal, CNN reported."US stocks enter April's final week with cautiously optimistic momentum, driven by (artificial intelligence) earnings beats and resilient macro prints," Ivan Feinseth, chief market strategist of Tigress Financial Intelligence, said in a report e-mailed to. "However, heightened volatility looms ahead of the conclusion of the (Federal Open Market Committee) meeting on Wednesday, with expectations that the Fed will keep rates unchanged at (3.50% to 3.75%)."With the FOMC decision unlikely to surprise, the market is expected to focus on the policy statement and post-meeting remarks of Chair Jerome Powell, said David Doyle, head of economics at Macquarie Group."Given that elevated oil prices have persisted for nearly two months now, future guidance may shift somewhat," he said in a report e-mailed to. "This would be in contrast to March where there were limited changes made. Our view remains that the next policy move is likely to be a hike with the most likely timing in (the first half of 2027)."US Treasury yields were higher, with the 10-year rate up 3.1 basis points at 4.34% and the two-year rate rising 1.5 basis points to 3.81%.S&P 500 companies' quarterly earnings growth decelerated compared with figures from a week ago, but remained well ahead of expectations, Oppenheimer Asset Management's data showed Monday."The quarter appears to be off to a strong start," Oppenheimer Asset Management Chief Investment Strategist John Stoltzfus said, noting that earnings growth reported by 79% of the firms that have released their quarterly results exceeded analyst estimates.Technology giants Alphabet (GOOG, GOOGL), Apple (AAPL), Microsoft (MSFT), Amazon (AMZN) and Meta Platforms (META) are slated to release their latest financial results later this week.In company-specific news, Verizon Communications (VZ) lifted its full-year earnings outlook on Monday and reported a first-quarter bottom line above market estimates, while the telecommunications giant unexpectedly added postpaid phone subscribers in the three-month period. The company's shares rose 1.6%, the second-biggest gain on the Dow.Shares of Domino's Pizza (DPZ) tumbled 8.8%, the steepest decline on the S&P 500. The company reported weaker-than-expected first-quarter results on Monday, with the company's chief executive saying consumer uncertainty and inflation weighed on demand late in the quarter.Organon (OGN) shares surged nearly 17% after the healthcare company agreed to be acquired by Indian pharmaceutical firm Sun Pharmaceutical Industries in an all-cash deal with an enterprise value of about $11.75 billion.Gold was last down 1% at $4,694.80 per troy ounce, while silver shed 1.2% to $75.47 per ounce.

Dow JonesNasdaq CompositeS&P 500$AAPL$AMZN$DPZ$GOOG$GOOGL$META$MSFT$OGN$VZ
Sectors

Sector Update: Health Care Stocks Softer Late Afternoon

Health care stocks fell late Monday afternoon with the NYSE Health Care Index easing 0.2% and the State Street Health Care Select Sector SPDR ETF (XLV) losing 0.3%.The iShares Biotechnology ETF (IBB) shed 0.4%.In corporate news, Eli Lilly (LLY) agreed to acquire Ajax Therapeutics for up to $2.3 billion in cash. The deal includes an upfront payment and subsequent payouts based on the achievement of clinical and regulatory milestones. Lilly shares fell 1.6%.HCA Healthcare (HCA) may face pressure through at least H1 as investors rotate toward managed care, although better trends in March and in-line exchange dynamics support the longer-term outlook, RBC Capital Markets said. HCA Healthcare shares rose 3.2%.Organon (OGN) shares jumped 17% after the company agreed to be acquired by India's Sun Pharmaceutical Industries for $14 a share in cash, valuing the company at $11.75 billion.Moderna (MRNA) is facing a patent infringement lawsuit from CureVac, which alleged that Moderna's COVID-19 vaccine Spikevax used its proprietary mRNA technology without authorization, Reuters reported Saturday. Moderna shares fell 4.7%.

$HCA$LLY$MRNA$OGN
US Markets

Equities Mixed Intraday, Oil Rises Amid Stalled US-Iran Talks

US benchmark equity indexes were mixed intraday, while oil prices rose as investors wavered after peace talks between Washington and Tehran apparently stalled.The Dow Jones Industrial Average was down 0.1% at 49,161.3 after midday Monday, while the Nasdaq Composite edged up 0.1% to 24,856.1. The S&P 500 gained 0.1% to 7,169.8. Among sectors, consumer staples saw the biggest drop, while communication services paced the gainers.Brent crude was up 3.2% at $108.73 per barrel, while West Texas Intermediate crude rose 2.4% to $96.63.Iran's Foreign Minister Seyed Abbas Araghchi visited Pakistan twice over the weekend, while President Donald Trump called off US officials' previously announced trip to Islamabad.Iran has submitted a new proposal to reopen the Strait of Hormuz that includes delaying nuclear negotiations, Axios reported, citing a US official and two other sources."Brent crude trades at a three-week high as efforts to revive peace talks have stalled, with an Iranian proposal reportedly calling for nuclear negotiations to be postponed to a later stage," Saxo Bank said in a report.The strait, the world's most important chokepoint for crude flows, remains at a near-complete halt, with Iran and the US imposing their respective blockades of maritime traffic, Bloomberg News reported Sunday.Trump was scheduled to meet with top national security officials on Monday to discuss the new Iranian proposal, CNN reported."Oil is trading stronger this morning after attempts to get US-Iran peace talks back on track broke down, erasing hopes for a resumption of energy flows through the Strait of Hormuz anytime soon," ING Bank said in a note on Monday. "The lack of progress means the market is tightening every day, requiring oil prices to reprice at higher levels."US Treasury yields were higher intraday, with the 10-year rate up 3.8 basis points at 4.35% and the two-year rate rising 2.7 basis points to 3.82%.In company news, Verizon Communications (VZ) lifted its full-year earnings outlook on Monday and reported a first-quarter bottom line above market estimates, while the telecommunications giant unexpectedly added postpaid phone subscribers in the three-month period. The company's shares were up 2.6% intraday, the biggest gain on the Dow.Shares of Domino's Pizza (DPZ) were down 9.5%, the steepest decline on the S&P 500. The company reported weaker-than-expected first-quarter results on Monday, with the company's chief executive saying consumer uncertainty and inflation weighed on demand late in the quarter.Organon (OGN) shares surged 17% after the healthcare company agreed to be acquired by Indian pharmaceutical firm Sun Pharmaceutical Industries in an all-cash deal with an enterprise value of about $11.75 billion.Technology giants Alphabet (GOOG, GOOGL), Apple (AAPL), Microsoft (MSFT), Amazon (AMZN) and Meta Platforms (META) are slated to release their latest financial results later this week.Gold was down 1.1% at $4,688.80 per troy ounce, while silver shed 1.6% to $75.20 per ounce.

Dow JonesNasdaq CompositeS&P 500$AAPL$AMZN$DPZ$GOOG$GOOGL$META$MSFT$OGN$VZ
Sectors

Sector Update: Health Care Stocks Softer in Afternoon Trading

Health care stocks were lower Monday afternoon with the NYSE Health Care Index easing 0.1% and the State Street Health Care Select Sector SPDR ETF (XLV) decreasing 0.2%.The iShares Biotechnology ETF (IBB) shed 0.2%.In corporate news, Eli Lilly (LLY) said Monday it has agreed to acquire Ajax Therapeutics for up to $2.3 billion in cash. The deal includes an upfront payment and subsequent payouts based on the achievement of clinical and regulatory milestones, the company said. Lilly shares were down 0.5%.Organon (OGN) shares jumped 17% after the company agreed to be acquired by India's Sun Pharmaceutical Industries $14 a share in cash, valuing the company at $11.75 billion.Moderna (MRNA) is facing a patent infringement lawsuit from CureVac, which alleged that Moderna's COVID-19 vaccine Spikevax used its proprietary mRNA technology without authorization, Reuters reported Saturday. Moderna shares were falling 3.3%.Catalyst Pharmaceuticals (CPRX) is being considered as a potential acquisition by Italy's Angelini Pharma, Bloomberg reported. Catalyst shares rose past 6%.

$CPRX$LLY$MRNA$OGN
Sectors

Sector Update: Health Care

Health care stocks were steady to lower Monday afternoon with the NYSE Health Care Index little changed and the State Street Health Care Select Sector SPDR ETF (XLV) easing 0.2%.The iShares Biotechnology ETF (IBB) fell 0.1%.In corporate news, Organon (OGN) shares jumped 17% after the company agreed to be acquired by India's Sun Pharmaceutical Industries $14 a share in cash, valuing the company at $11.75 billion.

$OGN
Research

Research Alert: Organon To Be Acquired By Sun Pharma In A Surprise Deal Announcement Today

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:In a surprise announcement today, Sun Pharma, India's largest drugmaker and the fourth-largest specialty generic pharmaceutical firm globally, announced its agreement to acquire Organon for $14.00 per share in an all-cash deal valued at $11.75B enterprise value. The transaction, slated to close in early 2027, is expected to create a top 25 global pharmaceutical firn with ~$12.4B in combined revenue, making Sun Pharma a top three player in women's health, the seventh largest biosimilars company globally. We think this acquisition makes strategic sense as Organon has been facing performance and governance issues in the past year after an internal investigation found improper wholesale practices in the U.S. related to Organon's key contraceptive Nexplanon and the abrupt departure of the former CEO K. Ali. Shares of OGN jumped by 17% today after the news. We raise our target to $14.00 from $7.00, based on a P/E of 3.8x our 2027 EPS estimate.We keep our 2026 EPS estimate at $3.62 and our 2027 EPS estimate at $3.71.

$OGN
Sectors

Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday

Health care stocks were edging higher pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) marginally advancing.Organon (OGN) has agreed to be acquired by Sun Pharmaceutical Industries for $14 per share in an all-cash deal with an $11.75 billion enterprise valuation, the companies said. Shares of Organon were up more than 17% premarket.Oruka Therapeutics (ORKA) stock was up more than 34% after the company said 63.5% of patients treated with ORKA-001 achieved the primary endpoint of complete skin clearance at week 16 in a phase 2a trial in moderate-to-severe plaque psoriasis.Ligand Pharmaceuticals (LGND) shares were up more than 3% after the company said it has agreed to purchase biotechnology peer Xoma Royalty (XOMA) in an all-cash deal valued at roughly $739 million.

$IBB$LGND$OGN$ORKA$XLV$XOMA
Commodities

Exchange-Traded Funds Down, Equity Futures Mixed Pre-Bell Monday Amid Hormuz Uncertainty, Corporate Earnings

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.1%, and the actively traded Invesco QQQ Trust (QQQ) was 0.2% lower in Monday's premarket activity amid uncertainty surrounding the Strait of Hormuz reopening and corporate earnings for the prior quarter.US stock futures were mixed, with the S&P 500 Index futures down by 0.01%, Dow Jones Industrial Average futures slipping 0.1%, and Nasdaq futures gaining 0.1% before the start of regular trading.The Dallas Federal Reserve manufacturing survey for April will be released at 10:30 am ET.In premarket activity, bitcoin was down by 0.6%. Among cryptocurrency ETFs, the cryptocurrency fund ProShares Bitcoin Strategy ETF (BITO) was 0.1% higher, Ether ETF (EETH) retreated 0.02%, and Bitcoin & Ether Market Cap Weight ETF (BETH) declined by 0.02%.Power Play:Health CareThe State Street Health Care Select Sector SPDR ETF (XLV) declined by 0.1%, the Vanguard Health Care Index Fund (VHT) was up 0.7%, while the iShares US Healthcare ETF (IYH) slipped 1.1%. The iShares Biotechnology ETF (IBB) was flat.Organon (OGN) stock was up more than 16% premarket after the company agreed to be acquired by Sun Pharmaceutical Industries for $14 per share in an all-cash deal with an enterprise valuation of $11.75 billion.Winners and Losers:ConsumerThe State Street Consumer Staples Select Sector SPDR ETF (XLP) was down 0.1%, and the Vanguard Consumer Staples Index Fund ETF Shares (VDC) was up 0.2%. The iShares US Consumer Staples ETF (IYK) declined by 0.2%. The State Street Consumer Discretionary Select Sector SPDR ETF (XLY) lost 0.2%. The VanEck Retail ETF (RTH) was inactive, while the State Street SPDR S&P Retail ETF (XRT) was 0.3% lower.Domino's Pizza (DPZ) shares were down more than 4% pre-bell after the company reported lower-than-expected fiscal Q1 earnings and revenue.TechnologyThe State Street Technology Select Sector SPDR ETF (XLK) advanced by 0.2%, the iShares US Technology ETF (IYW) was 0.4% higher, and the iShares Expanded Tech Sector ETF (IGM) was up 0.5%. Among semiconductor ETFs, the State Street SPDR S&P Semiconductor ETF (XSD) gained by 0.6%, while the iShares Semiconductor ETF (SOXX) rose by 0.5%.Tower Semiconductor (TSEM) shares were up more than 4% in Monday's premarket activity after the company and Axiro Semiconductor said that Axiro's Ku- and X-band radar beamforming integrated circuits are now ready for deployment in critical defense systems.IndustrialThe State Street Industrial Select Sector SPDR ETF (XLI) advanced 0.02%, while the Vanguard Industrials Index Fund (VIS) gained 0.4% and the iShares US Industrials ETF (IYJ) was flat.Joby Aviation (JOBY) stock was up more than 3% before the opening bell after the company said it completed the first point-to-point electric vertical takeoff and landing passenger flights in New York.FinancialThe State Street Financial Select Sector SPDR ETF (XLF) retreated by 0.1%. Direxion Daily Financial Bull 3X Shares (FAS) was down 0.4%, while its bearish counterpart, Direxion Daily Financial Bear 3X Shares (FAZ), was 0.3% higher.HBT Financial (HBT) shares were up more than 1% pre-bell after the company reported higher Q1 adjusted earnings and operating revenue.EnergyThe iShares US Energy ETF (IYE) gained 0.02%, while the State Street Energy Select Sector SPDR ETF (XLE) was up by 0.5%.TotalEnergies (TTE) stock was up more than 1% before the opening bell after news reports that the company is running its Gonfreville, France, site at its full capacity to maintain the supply of oil to the domestic market.CommoditiesFront-month US West Texas Intermediate crude oil advanced by 0.7% to $95.07 per barrel on the New York Mercantile Exchange. Natural gas gained by 1% to reach $2.67 per 1 million British Thermal Units. The United States Oil Fund (USO) increased by 0.9%, while the United States Natural Gas Fund (UNG) was 3.7% higher.Gold futures for May were down by 0.4% at $4,720.60 an ounce on the Comex. Silver futures retreated by 0.8% to $76.36 an ounce. SPDR Gold Shares (GLD) was 0.3% lower, and the iShares Silver Trust (SLV) fell by 0.4%.

Dow JonesNasdaq CompositeS&P 500$BETH$BITO$DPZ$EEM$EETH$EXI$FAS$FAZ$GLD$HBT$IBB$IGM$IGV$IPK$IVV$IWM$IYE$IYH$IYJ$IYK$IYW$JOBY$OGN$PMR$QQQ$RTH$SLV$SOXX$SPY$TSEM$TTE$UNG$USO$VDC$VHT$VIS$XLE$XLF$XLI$XLK$XLP$XLV$XLY$XRT$XSD
Sectors

Sector Update: Health Care

Health care stocks were edging higher pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) and iShares Biotechnology ETF (IBB) marginally advancing.Organon (OGN) has agreed to be acquired by Sun Pharmaceutical Industries for $14 per share in an all-cash deal with an $11.75 billion enterprise valuation, the companies said. Shares of Organon were up more than 17% premarket.

$OGN
US Markets

Stocks Mostly Down Pre-Bell as Iran Reportedly Offers New Proposal to Open Strait of Hormuz

The benchmark US stock measures were mostly tracking in the red before the opening bell Monday as traders assess media speculation about Iran's new proposal to open the Strait of Hormuz.The S&P 500 and the Dow Jones Industrial Average declined 0.1% each in premarket activity, while the Nasdaq was up 0.1%. The Nasdaq and S&P 500 finished Friday's trading session with new closing highs, while the Dow was down.Iran has sent a new proposal to the US to reopen the crucial Strait of Hormuz, the world's most important chokepoint for crude flows, Axios reported, citing a US official and two sources with knowledge of the matter. The proposal reportedly includes postponing nuclear negotiations to a later stage.Shipment traffic through the Strait of Hormuz remains at a near-complete halt with Iran and the US imposing their respective blockades of maritime traffic, Bloomberg News reported Sunday.West Texas Intermediate crude oil rose 2.1% to $96.38 a barrel before the open, while Brent gained 2.3% to $107.77.President Donald Trump cancelled plans to send his representatives to Pakistan for negotiations with Iran, saying too much time has been "wasted on traveling.""We have all the cards, they have none!" Trump said in a social media post on Saturday. "If they want to talk, all they have to do is call!!!"Iranian Foreign Minister Seyed Abbas Araghchi travelled to Islamabad over the weekend to convey Tehran's "observations" to Pakistan's high-level officials, foreign ministry spokesman Esmaeil Baqaei said in a post on X. There was no meeting planned with the US, according to Baqaei.Trump last week extended a ceasefire with Iran, but maintained the naval blockade of Iranian ports.The personal income and outlays report for March is scheduled to be released on Thursday. The report includes the personal consumption expenditure core price index, the Federal Reserve's preferred inflation metric.US consumer sentiment improved from an initial April estimate, but remained at a record low as near-term inflation expectations logged the biggest monthly increase in a year, final University of Michigan survey results showed Friday.Monday's thin economic calendar has the Dallas Fed manufacturing survey for April at 10:30 am ET.Technology giants Alphabet (GOOG, GOOGL), Apple (AAPL), Microsoft (MSFT), Amazon (AMZN) and Meta Platforms (META) are slated to release their latest financial results later this week.Verizon Communications (VZ) and Domino's Pizza (DPZ) report their earnings before the bell, while Cadence Design Systems (CDNS) announces its financial statement after the markets close.Organon (OGN) shares climbed 16% pre-bell after the healthcare firm agreed to be acquired by India's Sun Pharmaceutical Industries in an all-cash deal worth about $11.75 billion. Qualcomm (QCOM) added 13% after finishing the previous trading session up 11%, while Nvidia (NVDA) increased 1%.Treasury yields were trending upwards in premarket action, with the two-year rate inclining 1.3 basis points to 3.79% and the 10-year rate moving 0.6 basis points higher to 4.32%.Gold slipped 0.5% to $4,718 per troy ounce, while bitcoin decreased 0.6% to $77,804.

Dow JonesNasdaq CompositeS&P 500$AAPL$AMZN$CDNS$DPZ$GOOG$GOOGL$META$MSFT$NVDA$OGN$QCOM$VZ
US Markets

Organon Agrees to Be Acquired by Sun Pharmaceutical in $11.75 Billion Deal

Organon (OGN) shares spiked early Monday after the healthcare company agreed to be acquired by Indian pharmaceutical firm Sun Pharmaceutical Industries in an all-cash deal with an enterprise value of about $11.75 billion.Shareholders of Organon will receive $14 a share in cash under the terms of the transaction, the companies said in a joint statement on Sunday. Organon's stock jumped 15% in the most recent premarket activity."Following a comprehensive review of strategic alternatives, our board determined that this all-cash transaction offers compelling and immediate value to Organon stockholders," Organon Chief Executive Carrie Cox said in the statement. "We believe Sun Pharma is well positioned to support Organon's businesses, employees and patients globally."Organon, which focuses on women's health, was formed in 2021 following its separation from pharmaceutical giant Merck (MRK).The deal, which requires approval from regulators and clearance from Organon's shareholders, is expected to complete early next year."This transaction is a logical next step in strengthening Sun Pharma's global business," according to Sun Pharma Managing Director Kirti Ganorkar. "In addition, there is a scope for synergies including significant revenue upside opportunities to be realized over the coming years."Sun Pharma intends to fund the acquisition through a combination of available cash resources and committed financing from banks. The Indian company anticipates the transaction to allow it to enter the biosimilar market.For the year ended Dec. 31, Organon reported revenue of $6.22 billion and adjusted earnings before interest, taxes, depreciation and amortization of $1.91 billion. In February, the company said it expected revenue of $6.2 billion for the current year, while five analysts polled by FactSet estimate $6.15 billion.

$OGN
Sectors

Sector Update: Health Care Stocks Fall Late Afternoon

Health care stocks were lower late Friday afternoon, with the NYSE Health Care Index down 1.1% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 1.4%.The iShares Biotechnology ETF (IBB) fell 1%.In sector news, the US Food and Drug Administration said it was launching regulatory actions to back the development of psychedelic therapies to treat mental illness. The move builds on President Donald Trump's recent executive order directing the Department of Health and Human Services to accelerate access to treatments for people with serious mental illness, the FDA said.In corporate news, HCA Healthcare's (HCA) Q1 results exceeded market expectations, but the hospital operator said it did not see its usual seasonal lift in admissions amid declines in respiratory activity. Its shares dropped 9%.Organon (OGN) shares surged 32% amid a report that India's Sun Pharmaceutical Industries was planning a $13 billion bid for the company.Compass Pathways (CMPS) shares rose 4.8% after it said Friday the US Food and Drug Administration has granted its rolling review request for its new drug application and selected COMP360 for the Commissioner's National Priority Voucher program for treatment-resistant depression.Sanofi (SNY) priced a 2.3 billion euro ($2.7 billion) offering of notes under its Euro Medium Term Note program. Its shares were down 1.5%.

$CMPS$HCA$OGN$SNY
Sectors

Sector Update: Health Care Stocks Decline in Afternoon Trading

Health care stocks were lower Friday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each shedding 1.4%.The iShares Biotechnology ETF (IBB) decreased 0.7%.In sector news, the US Food and Drug Administration said it was launching regulatory actions to back the development of psychedelic therapies to treat mental illness. The move builds on President Donald Trump's recent executive order directing the Department of Health and Human Services to accelerate access to treatments for people with serious mental illness, the FDA said.In corporate news, HCA Healthcare's (HCA) Q1 results exceeded market expectations, but the hospital operator said it did not see its usual seasonal lift in admissions amid declines in respiratory activity. Its shares dropped 9%.Organon (OGN) shares surged 28% amid a report that India's Sun Pharmaceutical Industries was planning a $13 billion bid for the company.Compass Pathways (CMPS) shares rose 5% after it said Friday the US Food and Drug Administration has granted its rolling review request for its new drug application and selected COMP360 for the Commissioner's National Priority Voucher program for treatment-resistant depression.

$CMPS$HCA$OGN
Sectors

Sector Update: Health Care Stocks Mixed Premarket Friday

Health care stocks were mixed premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.7% and the iShares Biotechnology ETF (IBB) 0.5% higher.HCA Healthcare (HCA) stock was down 9% even after the company reported higher Q1 adjusted earnings and revenue.Organon (OGN) shares were up more than 29% amid a report that India's Sun Pharmaceutical Industries was planning a $13 billion bid for the company.Senseonics (SENS) stock was up 1.6% after the company said it has launched the Eversense 365 continuous glucose monitoring system in Europe.

$HCA$IBB$OGN$SENS$XLV
Commodities

Exchange-Traded Funds Rise, Equity Futures Mixed Pre-Bell as Traders Assess Tech Earnings Amid Global Uncertainty

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.4% and the actively traded Invesco QQQ Trust (QQQ) was 1.3% higher in Friday's premarket activity as investors assess technology companies' earnings while global uncertainty persists amid the Middle East conflict.US stock futures were mixed, with S&P 500 Index futures up 0.4%, Dow Jones Industrial Average futures slipping 0.1%, and Nasdaq futures gaining 1.3% before the start of regular trading.The University of Michigan consumer sentiment report for the current month is scheduled to be released at 10 am ET, while the weekly Baker Hughes domestic oil-and-gas rig count is due at 1 pm ET.In premarket activity, bitcoin was up by 0.7%. Among cryptocurrency ETFs, the cryptocurrency fund ProShares Bitcoin Strategy ETF (BITO) was 0.6% higher, Ether ETF (EETH) advanced 0.6%, and Bitcoin & Ether Market Cap Weight ETF (BETH) declined by 0.02%.Power Play:Health CareThe State Street Health Care Select Sector SPDR ETF (XLV) retreated by 0.5%, the Vanguard Health Care Index Fund (VHT) was down 0.1%, while the iShares US Healthcare ETF (IYH) was 0.1% lower. The iShares Biotechnology ETF (IBB) was 0.5% higher.Organon (OGN) shares were up 29% in Friday's premarket activity, a day after a media report that India's Sun Pharmaceutical Industries was planning a $13 billion bid for Organon.Winners and Losers:TechnologyThe State Street Technology Select Sector SPDR ETF (XLK) advanced by 2.1%, and the iShares US Technology ETF (IYW) was 1.7% higher, while the iShares Expanded Tech Sector ETF (IGM) was up 2.3%. Among semiconductor ETFs, the State Street SPDR S&P Semiconductor ETF (XSD) was 4.2% higher, while the iShares Semiconductor ETF (SOXX) rose by 4.1%.Intel (INTC) stock was 28% higher pre-bell Friday after the company reported overnight higher fiscal Q1 adjusted earnings and revenue in addition to providing fiscal Q2 outlook that surpassed analyst estimates.ConsumerThe State Street Consumer Staples Select Sector SPDR ETF (XLP) was down 0.1% and the Vanguard Consumer Staples Index Fund ETF Shares (VDC) was up 0.1%. The iShares US Consumer Staples ETF (IYK) was 0.04% higher and the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) gained 0.8%. The VanEck Retail ETF (RTH) and the State Street SPDR S&P Retail ETF (XRT) were flat.Coursera (COUR) stock was 16% lower before the opening bell on Friday after the company reported overnight lower Q1 non-GAAP earnings that also trailed analysts' estimates.FinancialThe State Street Financial Select Sector SPDR ETF (XLF) slipped 0.4%. Direxion Daily Financial Bull 3X Shares (FAS) was down 0.9%, while its bearish counterpart, Direxion Daily Financial Bear 3X Shares (FAZ), was 1.1% higher.Hartford Insurance Group (HIG) shares were down 4.4% before Friday's bell, a day after the company posted lower-than-expected Q1 core earnings and revenue.EnergyThe iShares US Energy ETF (IYE) retreated by 1%, while the State Street Energy Select Sector SPDR ETF (XLE) was down by 1.1%.SLB (SLB) shares were down 3.7% before Friday's bell after the company posted lower Q1 adjusted earnings.IndustrialThe State Street Industrial Select Sector SPDR ETF (XLI) retreated by 0.7%, while the Vanguard Industrials Index Fund (VIS) was 0.2% lower and the iShares US Industrials ETF (IYJ) was flat.Norfolk Southern (NSC) shares were down 1.1% before the opening bell Friday after the company reported lower Q1 adjusted EPS.CommoditiesFront-month US West Texas Intermediate crude oil retreated by 1.3% to $94.63 per barrel on the New York Mercantile Exchange. Natural gas declined by 2.4% to $2.70 per 1 million British Thermal Units. The United States Oil Fund (USO) decreased by 1.4%, while the United States Natural Gas Fund (UNG) was 1.7% lower.Gold futures for May were down by 0.1% at $4,721.50 an ounce on the Comex. Silver futures gained by 0.9% to reach $76.17 an ounce. SPDR Gold Shares (GLD) was 0.4% higher, and the iShares Silver Trust (SLV) advanced by 0.5%.

Dow JonesNasdaq CompositeS&P 500$BETH$BITO$COUR$EEM$EETH$EXI$FAS$FAZ$GLD$HIG$IBB$IGM$IGV$INTC$IPK$IVV$IWM$IYE$IYH$IYJ$IYK$IYW$NSC$OGN$PMR$QQQ$RTH$SLB$SLV$SOXX$SPY$UNG$USO$VDC$VHT$VIS$XLE$XLF$XLI$XLK$XLP$XLV$XLY$XRT$XSD
Wire

Market Chatter: Organon Shares Rise Pre-Bell Amid Report of Sun Pharmaceutical's Proposed $13 Billion Bid

Organon (OGN) shares rose more than 7% in Friday's premarket activity amid a report that India's Sun Pharmaceutical Industries was planning a $13 billion bid for the company.Organon would merge with Sun Pharmaceutical if an agreement is reached, according to a report from the Economic Times. Sun Pharma is competing with other major players, the report added.Organon and Sun Pharmaceutical did not immediately respond to' requests for comment.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $9.28, Change: $+0.68, Percent Change: +7.89%

$OGN
Sectors

Sector Update: Health Care Stocks Slide in Afternoon Trading

Health care stocks declined Thursday afternoon, with the NYSE Health Care Index decreasing 0.8% and the State Street Health Care Select Sector SPDR ETF (XLV) falling 1%.The iShares Biotechnology ETF (IBB) dropped 1.2%.In corporate news, Abbott Laboratories (ABT) lowered its full-year earnings outlook on Thursday to reflect the acquisition of cancer diagnostics company Exact Sciences, while the healthcare firm reported Q1 results above market estimates. Its shares fell past 6%.QuidelOrtho (QDEL) shares tumbled 31%. The company said late Wednesday it expects preliminary unaudited revenue of $615 million to $620 million for Q1. Analysts polled by FactSet expect $677.8 million.Hims & Hers Health (HIMS) shares rose past 7% after a senior US health official signaled plans to ease restrictions on certain peptides.Organon (OGN) is a potential acquisition target by India's Sun Pharmaceutical Industries, Germany's Grunenthal, and private equity firms, Bloomberg reported. Organon shares added 0.7%.

$ABT$HIMS$OGN$QDEL

Showing 1-20 of 23